Dompe- Global Regulatory Affairs Postdoctoral Research Fellow
About the Opportunity
About the Opportunity
Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education and training of Pharm.D. graduates. A key element of the program's success is preparing Fellows to meet evolving workforce needs across various sectors of the pharmaceutical industry.
Fellows have the opportunity to work closely with our innovative biopharmaceutical industry partners, while engaging with Northeastern University faculty in professional and career development, teaching, service, and scholarly activities.
In partnership with Northeastern University, Dompé is offering a two-year Global Regulatory Affairs fellowship, based remotely.
About Dompé
Dompé is an Italian bio-pharmaceutical company that focuses on innovation, where a long tradition in the field of personal wellness goes hand-in-hand with a commitment to research and development to meet unsatisfied therapeutic needs. Established in 1940 in Milan, Dompé has an industrial and biotech research hub in L'Aquila, in addition to branches in Europe (Barcelona, Berlin, Paris and Tirana). The company has approximately 1000 employees. The US headquarters of Dompé are based in Boston (R&D) and in the San Francisco Bay Area (Commercial Operations).
Responsibilities
The PharmD fellow will gain hands-on training in global drug development and regulatory strategy. Over two years, the fellow will support submission of industry's regulatory new drug applications (INDs, CTAs, NDAs/BLAs), labeling, and health authorities' interactions, while collaborating with cross functional teams across Clinical, Safety and CMC. The program also includes a 6-month rotation in Commercial Regulatory Affairs, providing exposure to advertising, promotion, and labeling compliance.
- Regulatory Strategy & Submissions: Support preparation of INDs, CTAs, NDAs/BLAs, orphan drug applications, pediatric plans, briefing documents, and Health Authority responses; participate in FDA, EMA, and PMDA meetings.

